(Q36212421)

English

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Charles M. Perou

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Olufunmilayo Olopade

17

object named as

Olufunmilayo I Olopade

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1

object named as

Laura J Esserman

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Constance D Lehman

15

object named as

Constance Lehman

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

18

object named as

Hope S Rugo

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

16

object named as

Minetta C Liu

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

8

object named as

Joe W Gray

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Donald A Berry

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Angela DeMichele

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lisa Carey

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sarah E Davis

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Meredith Buxton

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Cliff Hudis

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Christina Yau

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Chad Livasy

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Helen Krontiras

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Leslie Montgomery

13

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Debasish Tripathy

14

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

John T Carpenter

19

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lynn Dressler

20

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

David Chhieng

21

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Baljit Singh

22

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Carolyn Mies

23

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Joseph Rabban

24

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yunn-Yi Chen

25

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dilip Giri

26

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Laura van 't Veer

27

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Nola Hylton

28

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

29 May 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

30

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

26

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

3242-3249

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Effect of screening and adjuvant therapy on mortality from breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Challenges in breast cancer clinical trial design in the postgenomic era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

1 October 2017

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

29 June 2018

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

29 June 2018

Self-reported drug use: results of selected empirical investigations of validity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

29 June 2018

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

22 September 2018

Efficiency in the health care industries: a view from the outside.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

22 September 2018

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

22 September 2018

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3434983

5 December 2018

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally Advanced Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of initial clinical disease stage after achieving pathological complete response

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2011.39.2779

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

release_35sryjmjzzg4xjfji6a3akglqm

1 reference

https://api.fatcat.wiki/v0/release/35sryjmjzzg4xjfji6a3akglqm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36212421&oldid=1988231951"